Integrator Complex Subunit 2 (INTS2) (N-Term) Peptide
INTS2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all INTS2 products
- INTS2 (Integrator Complex Subunit 2 (INTS2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VCRGLIKNGE RQDEESLGGR RRTDALRFLC KMNPSQALKV RGMVVEECHL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-INTS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- INTS2 (Integrator Complex Subunit 2 (INTS2))
- Background
-
INTS2 is a subunit of the Integrator complex, which associates with the C-terminal domain of RNA polymerase II large subunit (POLR2A, MIM 180660) and mediates 3-prime end processing of small nuclear RNAs U1.
Alias Symbols: INT2, KIAA1287
Protein Size: 1204 - Molecular Weight
- 134 kDa
- Gene ID
- 57508
- NCBI Accession
- NM_020748, NP_065799
- UniProt
- Q9H0H0
-
You are here:
